PCSK9 and metabolic syndrome: The PCSK9 concentration was significantly greater in T1D patients with a high WC, TG ≥ 1.7 mmol/L, dyslipidemia, HbA1c > 7.5% (58 mmol/mol), or an iEAT above the 75th percentile (Fig. 1).